Follow
Maria Lagadinou
Maria Lagadinou
Eπικουρος Kαθηγητης
Verified email at upatras.gr
Title
Cited by
Cited by
Year
Antimicrobial properties on non-antibiotic drugs in the era of increased bacterial resistance
M Lagadinou, MO Onisor, A Rigas, DV Musetescu, D Gkentzi, ...
Antibiotics 9 (3), 107, 2020
952020
Fatigue and depressive symptoms associated with chronic viral hepatitis patients’ health-related quality of life (HRQOL)
K Karaivazoglou, G Iconomou, C Triantos, T Hyphantis, K Thomopoulos, ...
Annals of hepatology 9 (4), 419-427, 2010
952010
Prognosis of COVID-19: Changes in laboratory parameters
M Lagadinou, EE Solomou, N Zareifopoulos, M Marangos, C Gogos, ...
Age (yrs) 62 (13.4), 47-16.42, 2020
882020
N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study
SF Assimakopoulos, D Aretha, D Komninos, D Dimitropoulou, ...
Infectious Diseases 53 (11), 847-854, 2021
602021
The use of IgM-enriched immunoglobulin in adult patients with sepsis
L Kakoullis, ND Pantzaris, C Platanaki, M Lagadinou, ...
Journal of Critical Care 47, 30-35, 2018
472018
Intubation and mechanical ventilation of patients with COVID-19: what should we tell them?
N Zareifopoulos, M Lagadinou, A Karela, G Karantzogiannis, D Velissaris
Monaldi Archives for Chest Disease 90 (1), 2020
382020
Procalcitonin and sepsis in the Emergency Department: an update.
D Velissaris, N Zareifopoulos, M Lagadinou, C Platanaki, K Tsiotsios, ...
European Review for Medical & Pharmacological Sciences 25 (1), 2021
372021
Peripheral inserted central catheter use and related infections in clinical practice: a literature update
D Velissaris, V Karamouzos, M Lagadinou, C Pierrakos, M Marangos
Journal of clinical medicine research 11 (4), 237, 2019
352019
Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial
T Karampitsakos, O Papaioannou, P Tsiri, M Katsaras, A Katsimpris, ...
Clinical Microbiology and Infection 29 (3), 372-378, 2023
302023
Acceptance of hepatitis B vaccination among health care workers in Western Greece
K Karaivazoglou, C Triantos, M Lagadinou, C Bikas, M Michailidou, ...
Archives of environmental & occupational health 69 (2), 107-111, 2014
292014
Neuropsychiatric effects of antiviral drugs
N Zareifopoulos, M Lagadinou, A Karela, O Kyriakopoulou, D Velissaris
Cureus 12 (8), 2020
212020
Alterations in lymphocyte subsets and monocytes in patients diagnosed with SARS-CoV-2 pneumonia: a mini review of the literature.
M Lagadinou, N Zareifopoulos, D Gkentzi, F Sampsonas, E Kostopoulou, ...
European Review for Medical & Pharmacological Sciences 25 (15), 2021
182021
SARS CoV-2-induced viral sepsis: the role of gut barrier dysfunction
SF Assimakopoulos, G Eleftheriotis, M Lagadinou, V Karamouzos, ...
Microorganisms 10 (5), 1050, 2022
172022
Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic
D Gkentzi, E Benetatou, A Karatza, A Kanellopoulou, S Fouzas, ...
Human vaccines & immunotherapeutics 17 (10), 3401-3407, 2021
172021
Management of COVID-19: the risks associated with treatment are clear, but the benefits remain uncertain
N Zareifopoulos, M Lagadinou, A Karela, C Platanaki, G Karantzogiannis, ...
Monaldi Archives for Chest Disease 90 (2), 2020
152020
Recurrent visceral leishmaniasis in an immunocompetent patient: a case report
M Lagadinou, D Dimitropoulou, SF Assimakopoulos, G Davoulos, ...
Journal of Medical Case Reports 7, 1-4, 2013
152013
Septic Thrombophlebitis Caused by Fusobacterium necrophorum in an Intravenous Drug User
D Dimitropoulou, M Lagadinou, T Papayiannis, V Siabi, CA Gogos, ...
Case reports in infectious diseases 2013, 2013
152013
Evaluation of plasma soluble urokinase plasminogen activator receptor levels in patients with COVID-19 and non-COVID-19 pneumonia: an observational cohort study
D Velissaris, M Lagadinou, T Paraskevas, E Oikonomou, V Karamouzos, ...
Journal of clinical medicine research 13 (9), 474, 2021
142021
Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case …
SF Assimakopoulos, V Karamouzos, G Eleftheriotis, M Lagadinou, ...
Pathogens 12 (2), 286, 2023
132023
Pathophysiology and management of Akathisia 70 years after the introduction of the chlorpromazine, the first antipsychotic.
N Zareifopoulos, M Katsaraki, P Stratos, V Villiotou, M Skaltsa, A Dimitriou, ...
European Review for Medical & Pharmacological Sciences 25 (14), 2021
132021
The system can't perform the operation now. Try again later.
Articles 1–20